Advanced Biomed Inc. Common Stock (ADVB) is a publicly traded Healthcare sector company. As of May 21, 2026, ADVB trades at $4.36 with a market cap of $7.47M and a P/E ratio of -28.16. ADVB moved +0.00% today. Year to date, ADVB is -34.05%; over the trailing twelve months it is -81.51%. Its 52-week range spans $3.61 to $82.00. Rallies surfaces ADVB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Advanced Biomed Executes 1-for-20 Reverse Split, Reduces Shares to 1.36M: Advanced Biomed will implement a 1-for-20 reverse stock split on February 20, 2026, reducing its issued shares from 27,290,710 to approximately 1,364,536 to satisfy Nasdaq’s $1.00 minimum bid requirement. The consolidation will not alter ownership percentages and eliminates fractional share issuance.
| Metric | Value |
|---|---|
| Price | $4.36 |
| Market Cap | $7.47M |
| P/E Ratio | -28.16 |
| EPS | $-0.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $82.00 |
| 52-Week Low | $3.61 |
| Volume | 516 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-3.26M |
| Gross Margin | 0.00% |
ADVB analyst coverage data. Average price target: $0.00.